Skip to main content
Erschienen in: Pediatric Cardiology 4/2021

29.01.2021 | Original Article

Association of Fetal Atrial Flutter with Neonatal Atrioventricular Re-entry Tachycardia Involving Accessory Pathway: A Link to be Remembered

verfasst von: Gulhan Tunca Sahin, Michael Lewis, Orhan Uzun

Erschienen in: Pediatric Cardiology | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

To investigate prenatal and postnatal outcomes of atrial flutter and its association with the development of a second tachycardia, following restoration of sinus rhythm, in the fetus or newborn. This study is a retrospective review of all fetuses that presented with atrial flutter from January 2001 to December 2019 at the University Hospital of Wales, Cardiff, UK. The specific type of arrhythmia, its time of appearance and clinical characteristics, echocardiographic findings, medical management, and postnatal outcomes were evaluated. Sixteen fetuses were diagnosed with atrial flutter (AFL). Thirteen fetuses had persistent AFL and three fetuses had intermittent AFL. Seven patients had hydrops, of which one had Ebstein’s anomaly and the other six had normal hearts. Three of the fetuses that presented with AFL were diagnosed at 20, 21, and 23 weeks’ gestation and the remainder were diagnosed in the third trimester. Thirteen patients with AFL received antiarrhythmic drugs and three were delivered without any treatment. Five fetuses with AFL developed atrioventricular reciprocating tachycardia following DC cardioversion after birth, and four of them exhibited pre-excitation on the ECG. These five patients (31.3%) required postnatal antiarrhythmic treatment for up to 2 years. Pre-excitation disappeared in two patients during follow-up and two asymptomatic patients with neonatal pre-excitation required accessory pathway ablation. Fetal atrial flutter has a strong association with atrioventricular reciprocating tachycardia and ventricular pre-excitation in the neonatal period. Therefore, electrocardiograms should be carefully reviewed in newborns following the initial resolution of atrial flutter.
Literatur
1.
Zurück zum Zitat Oudijk MA, Ruskamp JM, Ververs FF, Ambachtsheer EB, Stoutenbeek P, Visser GH, Meijboom EJ (2003) Treatment of fetal tachycardia with sotalol: transplacental pharmacokinetics and pharmacodynamics. J Am Coll Cardiol 42:765–770PubMedCrossRef Oudijk MA, Ruskamp JM, Ververs FF, Ambachtsheer EB, Stoutenbeek P, Visser GH, Meijboom EJ (2003) Treatment of fetal tachycardia with sotalol: transplacental pharmacokinetics and pharmacodynamics. J Am Coll Cardiol 42:765–770PubMedCrossRef
2.
Zurück zum Zitat Krapp M, Kohl T, Simpson JM, Sharland GK, Katalinic A, Gembruch U (2003) Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia. Heart 89:913–917PubMedPubMedCentralCrossRef Krapp M, Kohl T, Simpson JM, Sharland GK, Katalinic A, Gembruch U (2003) Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia. Heart 89:913–917PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Jaeggi ET, Carvalho JS, De Groot E, Api O, Clur SA, Rammeloo L, McCrindle BW, Ryan G, Manlhiot C, Blom NA (2011) Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study. Circulation 124:1747–1754PubMedCrossRef Jaeggi ET, Carvalho JS, De Groot E, Api O, Clur SA, Rammeloo L, McCrindle BW, Ryan G, Manlhiot C, Blom NA (2011) Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study. Circulation 124:1747–1754PubMedCrossRef
4.
Zurück zum Zitat van Engelen AD, Weijtens O, Brenner JI, Kleinman CS, Copel JA, Stoutenbeek P, Meijboom EJ (1994) Management outcome and follow-up of fetal tachycardia. J Am Coll Cardiol 24:1371–1375PubMedCrossRef van Engelen AD, Weijtens O, Brenner JI, Kleinman CS, Copel JA, Stoutenbeek P, Meijboom EJ (1994) Management outcome and follow-up of fetal tachycardia. J Am Coll Cardiol 24:1371–1375PubMedCrossRef
5.
Zurück zum Zitat Naheed ZJ, Strasburger JF, Deal BJ, Benson DW Jr, Gidding SS (1996) Fetal tachycardia: mechanisms and predictors of hydrops fetalis. J Am Coll Cardiol 27:1736–1740PubMedCrossRef Naheed ZJ, Strasburger JF, Deal BJ, Benson DW Jr, Gidding SS (1996) Fetal tachycardia: mechanisms and predictors of hydrops fetalis. J Am Coll Cardiol 27:1736–1740PubMedCrossRef
6.
Zurück zum Zitat Strasburger JF, Cuneo BF, Michon MM, Gotteiner NL, Deal BJ, McGregor SN, Oudijk MA, Meijboom EJ, Feinkind L, Hussey M, Parilla BV (2004) Amiodarone therapy for drug-refractory fetal tachycardia. Circulation 109:375–379PubMedCrossRef Strasburger JF, Cuneo BF, Michon MM, Gotteiner NL, Deal BJ, McGregor SN, Oudijk MA, Meijboom EJ, Feinkind L, Hussey M, Parilla BV (2004) Amiodarone therapy for drug-refractory fetal tachycardia. Circulation 109:375–379PubMedCrossRef
7.
Zurück zum Zitat DeVore GR (2005) Assessing fetal cardiac ventricular function. Semin Fetal Neonatal Med 10:515–541PubMedCrossRef DeVore GR (2005) Assessing fetal cardiac ventricular function. Semin Fetal Neonatal Med 10:515–541PubMedCrossRef
8.
Zurück zum Zitat Jaeggi E, Fouron JC, Drblik SP (1998) Fetal atrial flutter: diagnosis, clinical features, treatment, and outcome. J Pediatr 132:335–339PubMedCrossRef Jaeggi E, Fouron JC, Drblik SP (1998) Fetal atrial flutter: diagnosis, clinical features, treatment, and outcome. J Pediatr 132:335–339PubMedCrossRef
11.
Zurück zum Zitat Fujimura O, Klein GJ, Yee R, Sharma AD (1990) Mode of onset of atrial fibrillation in the Wolff-Parkinson-White syndrome: how important is the accessory pathway? J Am Coll Cardiol 15:1082–1086PubMedCrossRef Fujimura O, Klein GJ, Yee R, Sharma AD (1990) Mode of onset of atrial fibrillation in the Wolff-Parkinson-White syndrome: how important is the accessory pathway? J Am Coll Cardiol 15:1082–1086PubMedCrossRef
12.
Zurück zum Zitat Wacker-Gussmann A, Strasburger JF, Srinivasan S, Cuneo BF, Lutter W, Wakai RT (2016) Fetal atrial flutter: electrophysiology and associations with rhythms involving an accessory pathway. J Am Heart Assoc 5:6CrossRef Wacker-Gussmann A, Strasburger JF, Srinivasan S, Cuneo BF, Lutter W, Wakai RT (2016) Fetal atrial flutter: electrophysiology and associations with rhythms involving an accessory pathway. J Am Heart Assoc 5:6CrossRef
13.
Zurück zum Zitat O'Leary ET, Alexander ME, Bezzerides VJ, Drogosz M, Economy KE, Friedman KG, Pickard SS, Tworetzky W, Mah DY (2020) Low mortality in fetal supraventricular tachycardia: outcomes in a 30-year single-institution experience. J Cardiovasc Electrophysiol 31:1105–1113PubMedCrossRef O'Leary ET, Alexander ME, Bezzerides VJ, Drogosz M, Economy KE, Friedman KG, Pickard SS, Tworetzky W, Mah DY (2020) Low mortality in fetal supraventricular tachycardia: outcomes in a 30-year single-institution experience. J Cardiovasc Electrophysiol 31:1105–1113PubMedCrossRef
14.
Zurück zum Zitat Hahurij ND, Blom NA, Lopriore E, Aziz MI, Nagel HT, Rozendaal L, Vandenbussche FP (2011) Perinatal management and long-term cardiac outcome in fetal arrhythmia. Early Hum Dev 87:83–87PubMedCrossRef Hahurij ND, Blom NA, Lopriore E, Aziz MI, Nagel HT, Rozendaal L, Vandenbussche FP (2011) Perinatal management and long-term cardiac outcome in fetal arrhythmia. Early Hum Dev 87:83–87PubMedCrossRef
15.
Zurück zum Zitat Lisowski LA, Verheijen PM, Benatar AA, Soyeur DJ, Stoutenbeek P, Brenner JI, Kleinman CS, Meijboom EJ (2000) Atrial flutter in the perinatal age group: diagnosis, management and outcome. J Am Coll Cardiol 35:771–777PubMedCrossRef Lisowski LA, Verheijen PM, Benatar AA, Soyeur DJ, Stoutenbeek P, Brenner JI, Kleinman CS, Meijboom EJ (2000) Atrial flutter in the perinatal age group: diagnosis, management and outcome. J Am Coll Cardiol 35:771–777PubMedCrossRef
16.
Zurück zum Zitat Miyoshi T, Maeno Y, Sago H, Inamura N, Yasukochi S, Kawataki M, Horigome H, Yoda H, Taketazu M, Shozu M, Nii M, Hagiwara A, Kato H, Shimizu W, Shiraishi I, Sakaguchi H, Ueda K, Katsuragi S, Ikeda T, Yamamoto H, Hamasaki T (2017) Antenatal antiarrhythmic treatment for fetal tachyarrhythmias: a study protocol for a prospective multicentre trial. BMJ Open 7:e016597PubMedPubMedCentralCrossRef Miyoshi T, Maeno Y, Sago H, Inamura N, Yasukochi S, Kawataki M, Horigome H, Yoda H, Taketazu M, Shozu M, Nii M, Hagiwara A, Kato H, Shimizu W, Shiraishi I, Sakaguchi H, Ueda K, Katsuragi S, Ikeda T, Yamamoto H, Hamasaki T (2017) Antenatal antiarrhythmic treatment for fetal tachyarrhythmias: a study protocol for a prospective multicentre trial. BMJ Open 7:e016597PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Lulić Jurjević R, Podnar T, Vesel S (2009) Diagnosis, clinical features, management, and post-natal follow-up of fetal tachycardias. Cardiol Young 19:486–493PubMedCrossRef Lulić Jurjević R, Podnar T, Vesel S (2009) Diagnosis, clinical features, management, and post-natal follow-up of fetal tachycardias. Cardiol Young 19:486–493PubMedCrossRef
18.
Zurück zum Zitat Frohn-Mulder IM, Stewart PA, Witsenburg M, Den Hollander NS, Wladimiroff JW, Hess J (1995) The efficacy of flecainide versus digoxin in the management of fetal supraventricular tachycardia. Prenat Diagn 15:1297–1302PubMedCrossRef Frohn-Mulder IM, Stewart PA, Witsenburg M, Den Hollander NS, Wladimiroff JW, Hess J (1995) The efficacy of flecainide versus digoxin in the management of fetal supraventricular tachycardia. Prenat Diagn 15:1297–1302PubMedCrossRef
19.
Zurück zum Zitat Ebenroth ES, Cordes TM, Darragh RK (2001) Second-line treatment of fetal supraventricular tachycardia using flecainide acetate. Pediatr Cardiol 22:483–487PubMedCrossRef Ebenroth ES, Cordes TM, Darragh RK (2001) Second-line treatment of fetal supraventricular tachycardia using flecainide acetate. Pediatr Cardiol 22:483–487PubMedCrossRef
20.
Zurück zum Zitat Cunningham T, Uzun O, Morris R, Franciosi S, Wong A, Jeremiasen I, Sherwin E, Sanatani S (2017) The safety and effectiveness of flecainide in children in the current era. Pediatr Cardiol 38:1633–1638PubMedCrossRef Cunningham T, Uzun O, Morris R, Franciosi S, Wong A, Jeremiasen I, Sherwin E, Sanatani S (2017) The safety and effectiveness of flecainide in children in the current era. Pediatr Cardiol 38:1633–1638PubMedCrossRef
21.
Zurück zum Zitat Aliot E, Capucci A, Crijns HJ, Goette A, Tamargo J (2011) Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation. Europace 13:161–173PubMedCrossRef Aliot E, Capucci A, Crijns HJ, Goette A, Tamargo J (2011) Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation. Europace 13:161–173PubMedCrossRef
22.
Zurück zum Zitat Uzun O, Babaoglu K, Sinha A, Massias S, Beattie B (2012) Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment. Cardiol Young 22:372–380PubMedCrossRef Uzun O, Babaoglu K, Sinha A, Massias S, Beattie B (2012) Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment. Cardiol Young 22:372–380PubMedCrossRef
23.
Zurück zum Zitat Zielinsky P, Dillenburg RF, de Lima GG, Zimmer LP (1998) Fetal supraventricular tachyarrhythmias. Experience of a fetal cardiology referral center. Arq Bras Cardiol 70:337–340PubMedCrossRef Zielinsky P, Dillenburg RF, de Lima GG, Zimmer LP (1998) Fetal supraventricular tachyarrhythmias. Experience of a fetal cardiology referral center. Arq Bras Cardiol 70:337–340PubMedCrossRef
24.
Zurück zum Zitat Krapp M, Baschat AA, Gembruch U, Geipel A, Germer U (2002) Flecainide in the intrauterine treatment of fetal supraventricular tachycardia. Ultrasound Obstet Gynecol 19:158–164PubMedCrossRef Krapp M, Baschat AA, Gembruch U, Geipel A, Germer U (2002) Flecainide in the intrauterine treatment of fetal supraventricular tachycardia. Ultrasound Obstet Gynecol 19:158–164PubMedCrossRef
25.
Zurück zum Zitat Dunnigan A, Benson W Jr, Benditt DG (1985) Atrial flutter in infancy: diagnosis, clinical features, and treatment. Pediatrics 75:725–729PubMed Dunnigan A, Benson W Jr, Benditt DG (1985) Atrial flutter in infancy: diagnosis, clinical features, and treatment. Pediatrics 75:725–729PubMed
26.
Zurück zum Zitat Hinkle KA, Peyvandi S, Stiver C, Killen SAS, Weng HY, Etheridge SP, Puchalski MD (2017) Postnatal outcomes of fetal supraventricular tachycardia: a multicenter study. Pediatr Cardiol 38:1317–1323PubMedCrossRef Hinkle KA, Peyvandi S, Stiver C, Killen SAS, Weng HY, Etheridge SP, Puchalski MD (2017) Postnatal outcomes of fetal supraventricular tachycardia: a multicenter study. Pediatr Cardiol 38:1317–1323PubMedCrossRef
27.
Zurück zum Zitat Moodley S, Sanatani S, Potts JE, Sandor GG (2013) Postnatal outcome in patients with fetal tachycardia. Pediatr Cardiol 34:81–87PubMedCrossRef Moodley S, Sanatani S, Potts JE, Sandor GG (2013) Postnatal outcome in patients with fetal tachycardia. Pediatr Cardiol 34:81–87PubMedCrossRef
28.
Zurück zum Zitat Mazur A, Meisel S, Shotan A, Strasberg B (2005) The mechanism of sudden death in the Wolff-Parkinson-White syndrome. J Cardiovasc Electrophysiol 16:1393PubMedCrossRef Mazur A, Meisel S, Shotan A, Strasberg B (2005) The mechanism of sudden death in the Wolff-Parkinson-White syndrome. J Cardiovasc Electrophysiol 16:1393PubMedCrossRef
Metadaten
Titel
Association of Fetal Atrial Flutter with Neonatal Atrioventricular Re-entry Tachycardia Involving Accessory Pathway: A Link to be Remembered
verfasst von
Gulhan Tunca Sahin
Michael Lewis
Orhan Uzun
Publikationsdatum
29.01.2021
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 4/2021
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-021-02549-6

Weitere Artikel der Ausgabe 4/2021

Pediatric Cardiology 4/2021 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.